Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov 13;4(1):21.
doi: 10.1186/1868-7083-4-21.

DNA methylation of the IGF2/H19 imprinting control region and adiposity distribution in young adults

Affiliations

DNA methylation of the IGF2/H19 imprinting control region and adiposity distribution in young adults

Rae-Chi Huang et al. Clin Epigenetics. .

Abstract

Background: The insulin-like growth factor 2 (IGF2) and H19 imprinted genes control growth and body composition. Adverse in-utero environments have been associated with obesity-related diseases and linked with altered DNA methylation at the IGF2/H19 locus. Postnatally, methylation at the IGF2/H19 imprinting control region (ICR) has been linked with cerebellum weight. We aimed to investigate whether decreased IGF2/H19 ICR methylation is associated with decreased birth and childhood anthropometry and increased contemporaneous adiposity.DNA methylation in peripheral blood (n = 315) at 17 years old was measured at 12 cytosine-phosphate-guanine sites (CpGs), analysed as Sequenom MassARRAY EpiTYPER units within the IGF2/H19 ICR. Birth size, childhood head circumference (HC) at six time-points and anthropometry at age 17 years were measured. DNA methylation was investigated for its association with anthropometry using linear regression.

Results: The principal component of IGF2/H19 ICR DNA methylation (representing mean methylation across all CpG units) positively correlated with skin fold thickness (at four CpG units) (P-values between 0.04 to 0.001) and subcutaneous adiposity (P = 0.023) at age 17, but not with weight, height, BMI, waist circumference or visceral adiposity. IGF2/H19 methylation did not associate with birth weight, length or HC, but CpG unit 13 to 14 methylation was negatively associated with HC between 1 and 10 years. β-coefficients of four out of five remaining CpG units also estimated lower methylation with increasing childhood HC.

Conclusions: As greater IGF2/H19 methylation was associated with greater subcutaneous fat measures, but not overall, visceral or central adiposity, we hypothesize that obesogenic pressures in youth result in excess fat being preferentially stored in peripheral fat depots via the IGF2/H19 domain. Secondly, as IGF2/H19 methylation was not associated with birth size but negatively with early childhood HC, we hypothesize that the HC may be a more sensitive marker of early life programming of the IGF axis and of fetal physiology than birth size. To verify this, investigations of the dynamics of IGF2/H19 methylation and expression from birth to adolescence are required.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Percentage DNA methylation of each CpG unit of the ICR of the IGF2/H19 locus. Males are shown in shaded and females in open bars. Error bars show standard deviation.
Figure 2
Figure 2
Linear regression showing the effect of IGF2/H19 methylation principal components upon age 17 years anthropometry. The β-coefficient and 95% confidence interval of the principle components of IGF2/H19 methylation are shown for a unit change in anthropometric measure. Principal component 1 (indicated by gray shaded bars and solid confidence interval lines) reflects within subject mean of IGF2/H19 methylation. Principal component 2 (indicated by open bars and dotted confidence interval lines) reflects within-subject standard deviation of the IGF2/H19 methylation. * indicates a P-value <0.05 and ** indicates a P-value <0.005.

References

    1. Werner H, Le Roith D. New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia. Cell Mol Life Sci. 2000;57:932–942. doi: 10.1007/PL00000735. - DOI - PMC - PubMed
    1. Dechiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor-II gene disrupted by targeting. Nature. 1990;345:78–80. doi: 10.1038/345078a0. - DOI - PubMed
    1. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth-factors in embryonic and postnatal-growth. Cell. 1993;75:73–82. - PubMed
    1. Lui JC, Finkielstain GP, Barnes KM, Baron J. An imprinted gene network that controls mammalian somatic growth is down-regulated during postnatal growth deceleration in multiple organs. Am J Physiol Regul Integr Comp Physiol. 2008;295:R189–R196. doi: 10.1152/ajpregu.00182.2008. - DOI - PMC - PubMed
    1. Jones BK, Levorse J, Tilghmann SM. Deletion of a nuclease-sensitive region between the Igf2 and H19 genes leads to Igf2 misregulation and increased adiposity. Hum Mol Genet. 2001;10:807–814. doi: 10.1093/hmg/10.8.807. - DOI - PubMed

LinkOut - more resources